Purpose: The consideration of radiation exposure is becoming more important in metastatic melanoma due to improved prognoses. The aim of this prospective study was to investigate the diagnostic performance of whole-body (WB) magnetic resonance imaging (MRI) in comparison to computed tomography (CT) with 18F-FDG positron emission tomography (PET)/CT and 18F-PET/MRI together with a follow-up as the reference standard. Methods: Between April 2014 and April 2018, a total of 57 patients (25 females, mean age of 64 ± 12 years) underwent WB-PET/CT and WB-PET/MRI on the same day. The CT and MRI scans were independently evaluated by two radiologists who were blinded to the patients’ information. The reference standard was evaluated by two nuclear medicine specialists. The findings were categorized into different regions: lymph nodes/soft tissue (I), lungs (II), abdomen/pelvis (III), and bone (IV). A comparative analysis was conducted for all the documented findings. Inter-reader reliability was assessed using Bland–Altman procedures, and McNemar’s test was utilized to determine the differences between the readers and the methods. Results: Out of the 57 patients, 50 were diagnosed with metastases in two or more regions, with the majority being found in region I. The accuracies of CT and MRI did not show significant differences, except in region II where CT detected more metastases compared to MRI (0.90 vs. 0.68, p = 0.008). On the other hand, MRI had a higher detection rate in region IV compared to CT (0.89 vs. 0.61, p > 0.05). The level of agreement between the readers varied depending on the number of metastases and the specific region, with the highest agreement observed in region III and the lowest observed in region I. Conclusions: In patients with advanced melanoma, WB-MRI has the potential to serve as an alternative to CT with comparable diagnostic accuracy and confidence across most regions. The observed limited sensitivity for the detection of pulmonary lesions might be improved through dedicated lung imaging sequences.
10 January 2025 in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
Multiparametric MRI is a promising technique for noninvasive structural and functional imaging of the kidneys that is gaining increasing importance in clinical research. Still, there are no standardized recommendations for analyzing the acquired images and there is a need to further evaluate the accuracy and repeatability of currently recommended MRI parameters. The aim of the study was to evaluate the test-retest repeatability of functional renal MRI parameters using different image analysis strategies.Ten healthy volunteers were examined twice with a multiparametric renal MRI protocol including arterial spin labeling (ASL), diffusion-weighted imaging (DWI) with intravoxel incoherent motion (IVIM), blood-oxygen-dependent (BOLD) imaging, T1 and T2 mapping, and volumetry with an interval of one week. The quantitative results of both kidneys were determined by manual organ segmentation, ROI analysis, and automatic segmentation based on the nnUNet framework. Test-retest repeatability of each parameter was computed using the within-subject coefficient of variance (wCV) and the intraclass coefficient (ICC). Segmentation accuracy and inter-reader agreement were evaluated using the dice score.Structural tissue parameters (T1, T2) showed wCV (%) between 4 and 11 and an ICC between 0.2 and 0.8. Functional parameters (ASL, BOLD and DWI) showed wCV (%) between 3 and 38 and an ICC between 0.0 and 0.7. The highest variances between test-retest scans were observed in perfusion measurements with ASL and IVIM (wCV: 17–37%). Quantitative analysis of the cortex and medulla showed a better repeatability when acquired using manual segmentation compared to ROI-based image analysis. Comparable repeatability was achieved with manual and automatic segmentation of the total kidney.Reasonable repeatability was achieved for all MR parameters. Structural MR parameters showed better repeatability compared to functional parameters. ROI-based image analysis showed overall lower repeatability compared to manual segmentation. Comparable repeatability to manual segmentation as well as acceptable segmentation accuracy could be achieved with automatic segmentation.
Purpose: This study aims to develop and evaluate a fully automated deep learning‐driven postprocessing pipeline for multiparametric renal MRI, enabling accurate kidney alignment, segmentation, and quantitative feature extraction within a single efficient workflow. Methods: Our method has three main stages. First, a segmentation network delineates renal structures in high‐contrast images. Next, a deep learning‐based pairwise image registration algorithm maps the multiparametric image series to a common target and transfers the predicted annotations between the multiparametric images. Finally, clinically relevant quantitative parameters are extracted through region‐specific assessment of renal structure and function based on the aligned and segmented multiparametric data. We used five‐fold cross‐validation to compare the segmentation outcomes and extracted features with manual analyses in 24 patients with prostate cancer or neuroendocrine tumors and 10 healthy subjects, each undergoing repeated scans. Results: Our automated pipeline achieved high agreement with expert kidney segmentation while delivering significant alignment improvements through registration. Volumetric analysis showed a strong correlation ( r 0.9) with manual results, and feature extraction demonstrated high intraclass correlation coefficients with minimal bias. The complete processing pipeline, encompassing coregistration, segmentation, and feature extraction, required approximately 15 s per scan from raw input to final quantitative output. Conclusion: The study establishes a reliable automated pipeline for renal multiparametric MRI postprocessing. The achieved accuracy and efficiency can support improved diagnosis and treatment planning for patients with kidney disease.
Objective: The aim of this study was to evaluate the impact of PET/CT on clinical management of patients with germ cell tumors (GCTs) conducted in a real-world setting, including avoidance of invasive procedures, additional diagnostic imaging, and changes in treatment. Methods: Patients with GCTs were prospectively enrolled into a PET/CT registry study between May 2013 and April 2021. Intended patient management prior and after PET/CT was documented using standardized questionnaires. Changes in oncologic staging and clinical management after PET/CT were recorded, including planned treatment and planned additional diagnostics. Results: Forty-three male patients with GCTs were included consecutively in this study. After PET/CT, oncologic staging changed in 22/43 patients (51%), with upstaging in seven cases (16%), downstaging in ten cases (23%), and cancer relapse in five cases (11%). The number of patients with intended curative treatment remained stable, while a considerable change in intended therapeutic intervention was noted after PET/CT, with an increase in planned chemotherapy from three to eleven patients and a decrease in planned surgical resection from eleven to two patients. In addition, PET/CT contributed to preventing patients from intended invasive procedures including biopsy and surgery in 8/43 (19%) cases and from additional diagnostic procedures in 25 (58%) cases. Conclusion: With the use of FDG-PET/CT as a tool to guide patient management in GCTs, we observed a notable impact on clinical staging and a consequent reduction in the need for additional invasive and diagnostic procedures. These findings are expected to be even more consequential in the future as treatment modalities improve and the life expectancy of GCT patients further increases. Key Points: PET/CT considerably influences the clinical stage of GCT patients. PET/CT has remarkable influence on the choice of therapeutic interventions and reduces additional diagnostic procedures.
Objectives Renal toxicity is a recognized potential adverse effect of radiopharmaceutical therapy (RPT). While 177 Lu-based therapies are generally well tolerated, subtle therapy-related renal changes remain insufficiently characterized. This study investigated longitudinal renal alterations during 177 Lu-based RPT using multiparametric magnetic resonance imaging (mpMRI) and evaluated its potential for renal monitoring. Methods Twenty-three patients undergoing RPT with either [ 177 Lu]Lu-DOTATATE (n = 14) or [ 177 Lu]Lu-PSMA (n = 9) underwent renal mpMRI examinations before and during therapy with up to four treatment cycles. Imaging included arterial spin labeling, diffusion-weighted imaging with intravoxel incoherent motion analysis, blood oxygenation level-dependent imaging, T1 mapping, and volumetry. Renal scintigraphy, estimated glomerular filtration rate (eGFR), and absorbed renal radiation dose were assessed longitudinally. Results No significant decline in eGFR was observed during RPT after exclusion of two patients who developed urinary tract obstruction (p = 0.19). Longitudinal analysis revealed significant temporal changes in T1 values (p = 0.008) and perfusion fraction of IVIM (p = 0.005), as well as a modest decrease in the corticomedullary BOLD ratio (p = 0.020). No significant longitudinal changes were detected for other MRI or scintigraphic parameters. Absorbed renal radiation dose was not associated with changes in MRI-derived biomarkers, eGFR, or renal scintigraphy (all p > 0.05). Patients with urinary obstruction demonstrated distinct MRI abnormalities, including reduced renal blood flow (RBF) and altered BOLD metrics. Conclusions No clinically relevant renal functional deterioration or major imaging abnormalities were detected during contemporary 177 Lu-based RPT. Subtle longitudinal T1 increases may reflect mild structural tissue remodeling without measurable functional consequences. Renal mpMRI is feasible for non-invasive monitoring and may provide complementary information beyond conventional renal function assessment. Trial registration, DRKS, DRKS00018966, registered 10 October 2019; https://www.drks.de/search/de/results